Inhibitory cis-element-mediated decay of human papillomavirus type 16 L1-transcript in undifferentiated cells

Molecular and Cellular Biochemistry

Volumn 288, Issue 1-2, 2006, Pages 47-57

  Mori, Seiichiro ^a   Ozaki, Saori ^b   Yasugi, Toshiharu ^b   Yoshikawa, Hiroyuki ^c   Taketani, Yuji ^b   Kanda, Tadahito ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

HPV 16; Inhibitory RNA element; L1 protein

Indexed keywords

CAPSID PROTEIN; DNA DIRECTED RNA POLYMERASE; DNA FRAGMENT; FIREFLY LUCIFERASE; MESSENGER RNA; PROTEIN L1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; DOWN REGULATION; GENE INSERTION; GENETIC TRANSCRIPTION; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NORTHERN BLOTTING; RNA SPLICING; RNA STABILITY; RNA SYNTHESIS; RNA TRANSCRIPTION; STEADY STATE; WESTERN BLOTTING;

CAPSID PROTEINS; CELLS, CULTURED; CODON; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MUTATION; ONCOGENE PROTEINS, VIRAL; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA POLYMERASE I; RNA SPLICING; RNA STABILITY; RNA, MESSENGER; TRANSFECTION;

HUMAN PAPILLOMAVIRUS TYPE 16; MIRIDAE;

EID: 33748148320     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9117-7     Document Type: Article

References (37)

1. zur Hausen H: Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288: F55-F78, 1996
2. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology 324: 17-27, 2004
3. Stoler MH, Broker TR: In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol 17: 1250-1258, 1986
4. Laimins LA: The biology of human Fapillomaviruses: from warts to cancer. Infect Agents Dis 2: 74-86, 1993
5. O'Connor MJ, Stunkel W, Koh CH, Zimmermann H, Bernard HU: The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. J Virol 74: 401-410, 2000
6. Kukimoto I, Kanda T: Displacement of YY1 by differentiation-specific transcription factor hSkn-1a activates the P(670) promoter of human papillomavirus type 16. J Virol 75: 9302-9311, 2001
7. Kennedy IM, Haddow JK, Clements JB: Analysis of human papillomavirus type 16 late mRNA 3′ processing signals in vitro and in vivo. J Virol 64: 1825-1829, 1990
8. Tan W, Schwartz S: The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3′ untranslated region. J Virol 69: 2932-2945, 1995
9. Sokolowski M, Zhao C, Tan W, Schwartz S: AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors. Oncogene 15: 2303-2319, 1997
10. Sokolowski M, Furneaux H, Schwartz S, The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3′ untranslated region correlates with its affinity for the elav-like HuR protein. J Virol 73: 1080-1091, 1999
11. Dietrich-Goetz W, Kennedy IM, Levins B, Stanley MA, Clements JB: A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA. Proc Natl Acad Sci USA 94: 163-168, 1997
12. Furth PA, Choe WT, Rex JH, Byrne JC, Baker CC: Sequences homologous to 5′ splice sites are required for the inhibitory activity of papillomavirus late 3′ untranslated regions. Mol Cell Biol 14: 5278-5289, 1994
13. Koffa MD, Graham SV, Takagaki Y, Manley JL, Clements JB: The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels. Proc Natl Acad Sci USA 97: 4677-4682, 2000
14. Kennedy IM, Haddow JK, Clements JB: A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J Virol 65: 2093-2097, 1991
15. Sokolowski M, Tan W, Jellne M, Schwartz S: MRNA instability elements in the human papillomavirus type 16 L2 coding region. J Virol 72: 1504-1515, 1998
16. Collier B, Öberg D, Zhao X, Schwartz S: Specific inactivation of inhibitory sequences in the 5′ end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J Virol 76: 2739-2752, 2002
17. Öberg D, Collier B, Zhao X, Schwartz S: Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J Virol 77: 11674-11684, 2003
18. Leder C, Kleinschmidt JA, Wiethe C, Müller M: Enhancement of capsid gene expression: Preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol 75: 9201-9209, 2001
19. Tan W, Felber BK, Zolotukhin AS, Pavlakis GN, Schwartz S: Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J Virol 69: 5607-5620, 1995
20. Browne HM, Churcher MJ, Stanley MA, Smith GL, Minson AC: Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant. J Gen Virol 69: 1263-1273, 1988
21. Heino P, Dillner J, Schwartz S: Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles. Virology 214: 349-359, 1995
22. Sambrook JG, Aussell DW: Molecular Cloning: a laboratory manual, 3rd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2001
23. Ghoshal K, Majumder S, Datta J, Motiwala T, Bai S, Sharma SM, Frankel W, Jacob ST: Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression. J Biol Chem 279: 6783-6793, 2004
24. Pfleiderer C, Smid A, Bartsch I, Grummt I: An undecamer DNA sequence directs termination of human ribosomal gene transcription. Nucleic Acids Res 18: 4727-4736, 1990
25. Zhao X, Rush M, Schwartz S: Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J Virol 78:10888-10905, 2004
26. Chen CY, You Y, Shyu AB: Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of a c-fos protein-coding region determinant of mRNA instability. Mol Cell Biol 12: 5748-5757,1992
27. Schiavi SC, Wellington CL, Shyu AB, Chen CY, Greenberg ME, Belasco JG: Multiple elements in the c-fos protein-coding region facilitate deadenylation and decay by a mechanism coupled to translation. J Biol Chem 269: 3441-3448, 1994
28. Wisdom R, Lee W: The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev 5: 232-243, 1991
29. Bachurski CJ, Theodorakis NG, Coulson RM, Cleveland DW: An amino-terminal tetrapeptide specifies cotranslational degradation of beta-tubulin but not alpha-tubulin mRNAs. Mol Cell Biol 14: 4076-4086, 1994
30. Zheng X, Kelley K, Elnakat H, Yan W, Dorn T, Ratnam M: MRNA instability in the nucleus due to a novel open reading frame element is a major determinant of the narrow tissue specificity of folate receptor alpha. Mol Cell Biol 23: 2202-2212, 2003
31. Vannice JL, Taylor JM, Ringold GM: Glucocorticoid-mediated induction of alpha 1-acid glycoprotein: Evidence for hormone-regulated RNA processing. Proc Natl Acad Sci USA 81: 4241-4245, 1984
32. Narayan P, Towle HC: Stabilization of a specific nuclear mRNA precursor by thyroid hormone. Mol Cell Biol 5: 2642-2646, 1985
33. Vaessen RTM, Houweling A, Van der Eb AJ: Post-transcriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells. Science 235: 1486-1488, 1987
34. Leys EJ, Crouse GF, Kellems RE: Dihydrofolate reductase gene expression in cultured mouse cells is regulated by transcript stabilization in the nucleus. J Cell Biol 99: 180-187, 1984
35. Tobler A, Miller CW, Johnson KR, Selsted ME, Rovera G, Koeffler HP: Regulation of gene expression of myeloperoxidase during myeloid differentiation. J Cell Physiol 136: 215-225, 1988
36. Akahane K, Pluznik DH: Interleukin-4 inhibits interleukin-1 alpha-induced granulocyte-macrophage colony-stimulating factor gene expression in a murine B-lymphocyte cell line via downregulation of RNA precursor. Blood 79: 3188-3195, 1992
37. Meskini RE, Boudouresque F, Ouafik L: Estrogen regulation of peptidylglycine {alpha}-amidating monooxygenase messenger ribonucleic acid levels by a nuclear posttranscriptional event. Endocrinology 138: 5256-5265, 1997